Condensed Consolidated Statements of Cash Flows (Unaudited) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2025 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)
Operating activities
Net income	$ 40	$ 93	$ 89
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		67	78
Stock-based compensation expense		82	92
Deferred income taxes		24	5
Loss on Blue Chip Swap	0	1	3
Changes in assets and liabilities:
Receivables		(75)	39
Inventories		13	(3)
Current payables and accrued expenses		(66)	(37)
Deferred revenue		17	(97)
Other assets and liabilities		(11)	(22)
Net cash provided by operating activities		145	147
Investing activities
Expenditures for property and equipment		(10)	(17)
Additions to capitalized software		(1)	(1)
Other investing activities, net		(1)	(5)
Net cash used in investing activities		(12)	(23)
Financing activities
Repurchases of common stock		(102)	(186)
Repayments of long-term borrowings		(19)	(13)
Payments of finance leases		(51)	(54)
Other financing activities, net		3	(1)
Net cash used in financing activities		(169)	(254)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		22	(8)
Decrease in cash, cash equivalents and restricted cash		(14)	(138)
Cash, cash equivalents and restricted cash at beginning of period		421	486
Cash, cash equivalents and restricted cash at end of period	407	407	348
Supplemental cash flow disclosure:
Assets acquired under operating lease		2	1
Assets acquired under finance lease		67	25
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets:
Cash and cash equivalents	406	406
Restricted cash	1	1
Total cash, cash equivalents and restricted cash	$ 407	$ 407	$ 348